In a co-aggregation gene study involving autoimmune diseases such as primary Sjogren’s syndrome, systemic lupus erythematosus, and rheumatoid arthritis, PTPRC was found to exhibit significant differential protein expression in all three disease types. This evidence concerns the gene PTPRC and autoimmune disease.